The Complex Connection between Cannabis and Schizophrenia

The Complex Connection between Cannabis and Schizophrenia

By: Marc Manseau (editor), Michael T. Compton (editor)Paperback

Special OrderSpecial Order item not currently available. We'll try and order for you.


The Complex Connection between Cannabis and Schizophrenia provides an in-depth overview of the current state of research into the role that cannabis plays in schizophrenia, covering both the pathophysiological and the pharmacological implications. It addresses the epidemiology of cannabis use and the risks associated with its use, the biological aspects of the drug, its effects on the brain and the pharmacological possibilities of using cannabidiol to treat schizophrenia. It is the only book on the market devoted exclusively to examining the links between this very commonly used (and misused) drug and a specific set of devastating psychiatric illnesses, providing a comprehensive guide to our current understandings of this relationship. Marijuana is the most commonly used illicit drug globally, and is becoming increasingly decriminalized and even legalized worldwide. Among the numerous mental-health concerns related to the drug, there is mounting evidence of an intricate link between cannabis use and schizophrenia and related psychotic disorders. At the same time, there is promising evidence to suggest that cannabidiol, one of the many compounds found in cannabis that activates the brain's cannabinoid receptors, could prove to be an effective antipsychotic to treat schizophrenia.

About Author

Professor of Clinical Psychiatry, Columbia University College of Physicians and Surgeons, NY, USA Clinical Assistant Professor of Psychiatry, New York University School of Medicine, NY USA


1. Introduction to the Complex Connection between Cannabis Use and Psychosis, Psychotic Disorders, and Schizophrenia Marc W. Manseau and Michael T. Compton 2. The Epidemiology of Cannabis Use in the United States Wilson M. Compton and Beth Han 3. The Biology of Cannabis in the Brain, and the Endocannabinoid System David Louis Atkinson and Jeff. K. Abbott 4. Psychotomimetic and Cognitive Effects of 9-Tetrahydrocannabinol in Laboratory Settings John D. Cahill, Swapnil Gupta, Jose Cortes-Briones, Rajiv Radhakrishnan, Mohamed Sherif, Deepak C. D'Souza 5. Psychotomimetic and Cognitive Effects of Cannabis Use in the General Population Nadia Solowij 6. Effects of Cannabis Use among those with Schizotypy Angelo B. Cedeno 7. Effects of Cannabis Use among those at Clinical High Risk for Schizophrenia Brian O'Donoghue, Meredith McHugh, Barnaby Nelson, and Patrick McGorry 8. Cannabis-Induced Psychotic Disorders Luca Pauselli 9. Synthetic Cannabinoids and Synthetic Cannabinoid-Induced Psychotic Disorders Papanti Duccio, Schifano Fabrizio, and Orsolini Laura 10. Cannabis Use as an Independent Risk Factor for, or Component Cause of, Schizophrenia and Related Psychotic Disorders Jodi M. Gilman, Sara M. Sobolewski, and Anne Eden Evins 11. Cannabis Use as a Determinant of Earlier Age at Onset of Schizophrenia and Related Psychotic Disorders Claire Ransay Wan and Beth Broussard 12. The Prevalence of Cannabis Use, and Effects on Course and Outcomes, among Individuals with Schizophrenia and Related Psychotic Disorders Ana Fresan, Rebeca Robles-Garcia, and Carlos-Alfonso Tovilla-Zarate 13. The Treatment of Cannabis Use Disorders among Individuals with Psychotic Disorders Peter Bosanac, Ana Lusicic, and David J. Castle 14. Cannabidiol as a Potential Novel Therapeutic Agent for Psychotic Disorders Serena Deiana and Erica Zamberletti

Product Details

  • ISBN13: 9780128047910
  • Format: Paperback
  • Number Of Pages: 362
  • ID: 9780128047910
  • weight: 540
  • ISBN10: 0128047917

Delivery Information

  • Saver Delivery: Yes
  • 1st Class Delivery: Yes
  • Courier Delivery: Yes
  • Store Delivery: Yes

Prices are for internet purchases only. Prices and availability in WHSmith Stores may vary significantly